Document is current
Any future updates will be listed below
-
Authors
Guilbaud, Emma
Ryan, Kevin M.
Green, Douglas R.
Galluzzi, Lorenzo https://orcid.org/0000-0003-2257-8500
- License Information
-
More Information
Article History
Accepted: 30 March 2026
First Online: 18 May 2026
Competing interests
: D.R.G. is/has been holding research contracts with Amgen and has consulted for Sonata Pharmaceuticals, Ventus Pharmaceuticals and ASHA Therapeutics. L.G. is/has been holding research contracts with Lytix Biopharma, Promontory and Onxeo, has received consulting/advisory honoraria from Boehringer Ingelheim, AstraZeneca, OmniSEQ, Onxeo, The Longevity Labs, Inzen, Imvax, Sotio, Promontory, Noxopharm, EduCom and the Luke Heller TECPR2 Foundation and holds Promontory stock options. E.G. and K.M.R. have no conflicts of interest to disclose.
